PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27493016-1	2017	The objective of the study was to establish the dose-response relationship for robenacoxib, a selective cyclooxygenase (COX)-2 inhibitor, in a urate crystal model of acute synovitis.	robenacoxib	79-90	cytochrome c oxidase subunit II	Canis lupus familiaris	104-126	
27493016-7	2017	Robenacoxib significantly inhibited COX-2 at all doses, with dose-related activity.	robenacoxib	0-11	cytochrome c oxidase subunit II	Canis lupus familiaris	36-41